| Serial Number | 79422180 |
| Word Mark | PANAVIR |
| Filing Date | Friday, February 21, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Tuesday, September 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Nutritional supplements; pharmaceutical preparations for the treatment of viral infections and viral diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 24, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NEOPHARM OOD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BG |
| Event Date | Event Description |
| Thursday, April 24, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, April 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 25, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, July 28, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, August 5, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, September 14, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, September 20, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 4, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, September 14, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, September 23, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, September 20, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |